Investigation of computed tomography findings of portal hypertension at non-alcoholic fatty liver disease

被引:0
|
作者
Kulali, Fatma [1 ]
Kaya-Tuna, Burcu [1 ]
Semiz-Oysu, Aslihan [1 ]
Kilicoglu, Zeynep Gamze [2 ]
Bukte, Yasar [1 ]
机构
[1] Umraniye Training & Res Hosp, Istanbul, Turkey
[2] Haydarpasa Numune Training & Res Hosp, Istanbul, Turkey
关键词
Hepatosteatosis; Portal hypertension; Fatty liver; Cirrhosis;
D O I
10.1016/j.ejrnm.2016.05.012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Non-alcoholic fatty liver disease (NAFLD) is very common and serious disease. It begins as a simple hepatosteatosis but can progress to cirrhosis. The early detection of portal hypertension (HT) can be helpful in the management of these patients. Aims: To evaluate radiologic findings of portal hypertension at computed tomography (CT) of patients with non-alcoholic fatty liver disease for early diagnosis. Methods and materials: Images of 225 cases who underwent non-enhanced abdominal CT were reviewed. The patients with the difference between hepatic and splenic attenuation (CT L-S) > 10 were enrolled in hepatosteatosis group. The remainings formed control group. The relationship between two groups about diameters of portal and splenic veins, craniocaudal (CC) span of liver, splenic index, caudate lobe/right lobe (C/RL) ratio was analyzed statistically by Mann-Whitney U Test and Student's t-test. Results: Total 213 cases, as hepatosteatosis (n = 149) and control (n = 64) groups, were involved in this study. Liver CC span, splenic index and C/RL ratio between two groups were found to be statistically significant (p < 0.01). Conclusions: The splenic index and C/RL ratio are important findings of portal HT and fibrosis. CT imaging can be beneficial for diagnosis and treatment of NAFLD patients. (C) 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease in pregnancy
    Benson, Charlotte S.
    Cobbold, Jeremy F.
    Frise, Charlotte J.
    OBSTETRIC MEDICINE, 2023, 16 (02) : 116 - 119
  • [22] Prognosis of non-alcoholic fatty liver disease
    Lutz, H. H.
    Trautwein, C.
    Tacke, F.
    GASTROENTEROLOGE, 2010, 5 (02): : 129 - 133
  • [23] Iron and non-alcoholic fatty liver disease
    Laurence J Britton
    V Nathan Subramaniam
    Darrell HG Crawford
    World Journal of Gastroenterology, 2016, 22 (36) : 8112 - 8122
  • [24] Hypoxia and Non-alcoholic Fatty Liver Disease
    Isaza, Stephania C.
    del Pozo-Maroto, Elvira
    Dominguez-Alcon, Lucia
    Elbouayadi, Liliam
    Gonzalez-Rodriguez, Agueda
    Garcia-Monzon, Carmelo
    FRONTIERS IN MEDICINE, 2020, 7
  • [25] Non-alcoholic fatty liver disease in 2015
    Monjur Ahmed
    World Journal of Hepatology, 2015, (11) : 1450 - 1459
  • [26] Hypoxia and non-alcoholic fatty liver disease
    Byrne, Christopher D.
    CLINICAL SCIENCE, 2010, 118 (5-6) : 397 - 400
  • [27] Non-invasive tests of non-alcoholic fatty liver disease
    Li, Guanlin
    Zhang, Xinrong
    Lin, Huapeng
    Liang, Lilian Yan
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    CHINESE MEDICAL JOURNAL, 2022, 135 (05) : 532 - 546
  • [28] Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
    Tannapfel, A.
    Denk, H.
    Dienes, H. P.
    Langner, C.
    Schirmacher, P.
    Trauner, M.
    Flott-Rahmel, B.
    PATHOLOGE, 2010, 31 (03): : 225 - 237
  • [29] Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
    Tannapfel, Andrea
    Denk, Helmut
    Dienes, Hans-Peter
    Langner, Cord
    Schirmacher, Peter
    Trauner, Michael
    Flott-Rahmel, Berenike
    VIRCHOWS ARCHIV, 2011, 458 (05) : 511 - 523
  • [30] Histopathological Diagnose of Non-alcoholic and Alcoholic Fatty Liver Disease
    Tannapfel, A.
    Denk, H.
    Dienes, H. -P.
    Langner, C.
    Schirmacher, P.
    Trauner, M.
    Flott-Rahmel, B.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2010, 48 (04): : 486 - 498